Drug, Pharma Benefit Cos. Sued Over Insulin Pricing

By Dani Kass (March 9, 2017, 2:58 PM EST) -- Another set of diabetes patients on Wednesday filed a potential class action in New Jersey federal court against Novo Nordisk, Eli Lilly & Co. and Sanofi-Aventis for allegedly conspiring to drive up the price of insulin following pressures from pharmacy benefit managers Express Scripts, CVS Health and OptumRx....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!